Cite
MLA Citation
F. Jin et al.. “ACTIVATION OF THE AhR/ARNT PATHWAY IS ASSOCIATED WITH OUTCOME OF DLBCL PATIENTS AFTER TREATED WITH RITUXIMAB.” Hematological oncology, vol. 37, n.d., p. 364. http://access.bl.uk/ark:/81055/vdc_100086207301.0x000039